NCT00387790View on ClinicalTrials.gov

Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Untreated Childhood Brain Stem Glioma
Interventions
DRUG

motexafin gadolinium

Given IV

RADIATION

3-dimensional conformal radiation therapy

Undergo focal cranial radiotherapy

Trial Locations (1)

19104

Children's Oncology Group, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00387790 - Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | Biotech Hunter | Biotech Hunter